ENOV
ENOV
NYSE · Health Care

Enovis Corp

$24.42
+3.53 (+16.90%)
As of Nov 7, 1:51 AM ET ·
Financial Highlights (FY 2026)
Revenue
2.66B
Net Income
-1,402,770,312
Gross Margin
58.2%
Profit Margin
-52.7%
Rev Growth
+12.9%
D/E Ratio
0.87
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 58.2% 58.2% 66.5% 66.5%
Operating Margin -50.1% -45.1% 9.3% 10.1%
Profit Margin -52.7% -50.1% 7.8% 6.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.66B 2.36B 959.49M 1.06B
Gross Profit 1.55B 1.37B 638.34M 705.58M
Operating Income -1,333,610,999 -1,063,297,217 89.71M 107.61M
Net Income -1,402,770,312 -1,118,438,413 74.78M 72.61M
Gross Margin 58.2% 58.2% 66.5% 66.5%
Operating Margin -50.1% -45.1% 9.3% 10.1%
Profit Margin -52.7% -50.1% 7.8% 6.9%
Rev Growth +12.9% +12.9% -5.1% -8.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 384.06M 384.06M 570.05M 575.91M
Total Equity 441.19M 441.19M 642.51M 611.09M
D/E Ratio 0.87 0.87 0.89 0.94
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -909,411,126 -765,361,950 123.09M 130.61M
Free Cash Flow — — 63.08M 92.88M